Idiopathic hyperprolactinemia-associated hypogonadism in men presenting with normal testosterone levels

Area of Science:

• Endocrinology
• Urology

Background:

• Hyperprolactinemia is often associated with hypogonadism, characterized by low testosterone, suppressed gonadotropins, and elevated prolactin.
• A subset of men with hyperprolactinemia presents with hypogonadism despite normal testosterone levels, a condition poorly understood.

Purpose of the Study:

• To define the clinical characteristics of men with idiopathic hyperprolactinemia and normal testosterone levels.
• To evaluate the effectiveness of medical treatment in this patient cohort.

Main Methods:

• Retrospective analysis of 23 men with idiopathic hyperprolactinemia and normal testosterone.
• Evaluation of baseline clinical data, hormone levels, and pituitary gland dimensions via MRI.
• Assessment of treatment response to bromocriptine or cabergoline.

Main Results:

• The average age was 30.9 years, with mean prolactin levels of 38.22 ng/mL and pituitary height of 6.40 mm.
• Common symptoms included low libido, gynecomastia, and erectile dysfunction.
• Treatment with bromocriptine or cabergoline for ~8 months normalized prolactin, reduced pituitary height to 4.39 mm, and improved clinical symptoms.

Conclusions:

• Idiopathic hyperprolactinemia can cause hypogonadism with normal testosterone, necessitating clinical vigilance.
• Reduced pituitary height is a potential diagnostic marker and indicator of treatment efficacy.
• Bromocriptine and cabergoline are effective treatments, with cabergoline potentially preferred based on clinical factors.